Recent News

• 03.10.2025 - IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
• 02.13.2025 - IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share
• 01.30.2025 - IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
• 01.10.2025 - IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
• 12.19.2024 - IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• 12.10.2024 - IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025

Recent Filings

• 03.06.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.13.2025 - EX-99.1 EX-99.1
• 02.13.2025 - 8-K Current report
• 02.13.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.10.2025 - 8-K Current report
• 01.10.2025 - EX-99.1 EX-99.1
• 01.06.2025 - 144 Report of proposed sale of securities
• 12.13.2024 - 4 Statement of changes in beneficial ownership of securities
• 12.13.2024 - 4 Statement of changes in beneficial ownership of securities
• 12.13.2024 - 4 Statement of changes in beneficial ownership of securities